Foresight LabsA jacket, two journeys

GlobalStockholm Convention

POPRC.21 To Tackle Risk Profiles And Exemptions For Key POPs Including PFOS And MCCPs

POPRC.21 marks a pivotal step in the global regulation of POPs, with upcoming decisions on dioxin-like brominated compounds and per- and polyfluorinated substances. Industry professionals should track these developments to align with future legal requirements and sustainability goals.

Published in September 2025. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

3 min readAI-drafted, expert reviewed

People talking

The twenty-first meeting of the Persistent Organic Pollutants Review Committee (POPRC.21) under the Stockholm Convention will be held in Rome, Italy, from 29 September to 3 October 2025. The session will examine risk profiles and regulatory exemptions for several high-concern substances, including PFOS, MCCPs, and dioxin-like brominated compounds, with far-reaching implications for chemical manufacturers, importers, and downstream users.

Professionals in the chemicals industry and regulatory sectors should note that the outcomes of POPRC.21 could directly affect compliance obligations, product formulations, and international trade of substances under review.

New Risk Profile For Brominated Dioxins And Furans

The Committee will evaluate a draft risk profile for polybrominated dibenzo-p-dioxins and dibenzofurans, as well as mixed halogenated analogues. These substances were deemed to meet the Convention’s Annex D screening criteria at POPRC.20 and are now being considered for listing in Annex C, which targets unintentional production.

If listed, this would compel parties to take measures to reduce or eliminate releases through best available techniques (BAT) and best environmental practices (BEP). These compounds are by-products of industrial processes such as flame retardant manufacture, and their persistence and bioaccumulation pose serious environmental and human health risks.

Review Of PFOS And PFOI Exemptions Under Way

POPRC.21 will also begin evaluating the continued need for exemptions under Annex B for perfluorooctane sulfonic acid (PFOS), its salts, and perfluorooctane sulfonyl fluoride (PFOSF). These exemptions have allowed limited use in sectors such as plating, firefighting foams, and certain textiles.

In parallel, the Committee will assess a specific exemption for the use of perfluorooctyl iodide (PFOI) in producing perfluorooctyl bromide (PFOB) for pharmaceutical applications. Any recommendations will inform decisions at COP-13 in 2027.

Stakeholders in pharmaceuticals and high-performance coatings should closely monitor this process, as phasing out these exemptions could necessitate reformulation or substitution strategies.

Support For Future MCCPs Review Process

The Committee will determine how to support the planned reviews of medium-chain chlorinated paraffins (MCCPs) under Annex A. The review of the listing itself is scheduled for COP-14 in 2029, while exemptions will be addressed at COP-15 in 2031.

MCCPs are used in metalworking fluids, PVC products, and flame retardants. Companies in these sectors should anticipate future regulatory scrutiny and start evaluating alternatives where possible.

Indicative Lists And Annex Clarifications

POPRC.21 will finalise indicative lists of substances covered by listings of PFOA, PFHxS, PFOS, and long-chain perfluorocarboxylic acids (PFCAs). These documents help clarify which chemical variants fall under the Convention’s scope—vital for compliance teams performing substance inventory checks.

The Committee will also address implementation guidance for complex footnotes in Annexes A and B, providing further clarity for regulators and industry.

Questions about this change

What are the implications of listing brominated dioxins in Annex C?

If listed, these by-product POPs would require countries to minimise emissions using best available techniques (BAT). Industries such as electronics recycling or brominated flame retardant production may face stricter process controls.

Why is PFOS under review again?

The Stockholm Convention mandates periodic review of exemptions. With safer alternatives emerging, the continued need for PFOS in specific uses like firefighting foams and chrome plating is being re-evaluated to phase out unnecessary exposures.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Find out what this means for your products

Foresight follows changes like this one and shows where they reach your substances, products and markets.

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX